Solius Labs
Solius Labs develops an FDA-cleared over-the-counter UVB light therapy device that analyzes users' skin to deliver a personalized dose of UVB light, stimulating vitamin D production with minimal UV risk. The device is intended for adults seeking the health benefits of sunlight, such as improved bone health, mood, and skin conditions, in a safe and convenient at-home or professional setting. Solius Labs aims to make clinically proven UVB light therapy accessible and effective for supporting whole-body health.
Facts
- HQ
- Bainbridge Island, WA, US
- Sectors
- Medical Device
- Founded
- 2011
- Employees
- 30
- Stage
- Series A
- Members see funding amounts. .
Is this your organization? Claim it
Solius Labs Raises $23M Series A to Launch FDA-Cleared $2,995 At-Home UVB Light Therapy Device
Solius Labs, a Bainbridge Island startup founded in 2013, raised $23 million in Series A funding to launch the Solius Pro, a $2,995 FDA-cleared at-home UVB light therapy device that delivers safe, personalized vitamin D stimulating treatment via a smartphone-controlled wall-mounted unit. The device uses a patented skin-scanning sensor to customize UVB dosage in under five minutes per weekly session, enabling convenient home use previously only available in clinics.
Seattle Startup HouseAmp Raises $12.4M to Expand Home Improvement Financing Platform
Seattle-based startup HouseAmp raised $12.4 million to expand its fintech platform that helps homeowners secure funding for home improvements before selling. The company, founded in 2020 and led by CEO Rick Hennessey, plans growth following successful trials with lenders.
Solius raises investment from Human Longevity Inc. to test UV kiosks' vitamin D boost as possible way to reduce COVID-19 severity
Seattle startup Solius, which makes ultraviolet light therapy kiosks claimed to raise vitamin D, received new investment from Human Longevity Inc. as it explores clinical trials to test whether boosting vitamin D could reduce COVID-19 severity, following research that found correlations between low vitamin D and higher COVID-19 mortality.
People
See all 4-
Chris Kiple Executive, Executive Officer, Director, Chief Executive Officer
-
Chris Brooks Executive, Chief Strategy Officer
-
David Good Executive, Executive Officer, Chief Special Projects Officer
Online
Questions about Solius Labs
What is Solius Labs?
Solius Labs develops an FDA-cleared over-the-counter UVB light therapy device that analyzes users' skin to personalize UVB doses and stimulate vitamin D production. Solius Labs is based in Bainbridge Island, WA, US.
What has Solius Labs been in the news for?
GeekWire reported in June 2026 on Solius Labs' launch of an FDA-cleared at-home UVB light therapy device. In May 2020, GeekWire reported on testing UV kiosks' vitamin D boost as a possible way to reduce COVID-19 severity.
Who are the people behind Solius Labs?
Chris Kiple is chief executive officer at Solius Labs, and Chris Brooks is chief strategy officer. David Good is chief special projects officer, and Robert Wise is chief financial officer.
Who invested in Solius Labs, and how much has it raised?
Members of Seattle Flow see Solius Labs' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Solius Labs based?
Solius Labs is based in Bainbridge Island, WA, US.
When was Solius Labs founded?
Solius Labs was founded in 2011.